Nonalcoholic steatohepatitis (NASH) is a serious progressive liver disease that causes fat accumulation and inflammation that is not related to excess alcohol consumption. As a growing public health concern, NASH can progress to fibrosis, cirrhosis, liver cancer, and death and is a leading cause of liver failure requiring transplantation. Because NASH is directly related to the diabetes and obesity epidemics, continuing medical education (CME on NASH is a critical part of healthcare professional education. It is vital that practitioners stay updated on the emerging NASH treatment landscape so that they are well poised to treat patients when effective therapies become available. NASH CME and CE programs can help medical personnel and their patients understand the causes and consequences of NASH and the importance of early diagnosis and treatment that can reduce the chances of devastating NASH-related complications.